Literature DB >> 22674135

Detection of putative cancer stem cells of the side population phenotype in human tumor cell cultures.

Matthias Christgen1, Matthias Ballmaier, Ulrich Lehmann, Hans Kreipe.   

Abstract

Human solid tumors and clonal tumor cell lines comprise phenotypically and functionally diverse subsets of cancer cells and also contain stem cell-like cancer cells. Side population (SP) cells, which pump out the fluorescent dye Hoechst 33342 (H33342) via the ABCG2 transporter, define a fraction of adult tissue stem cells in a wide variety of organs. Rare cancer cells with similar H33342 efflux capacity and delimited expression of ABCG2 are present in various types of human tumors, such as breast cancer, lung cancer, and hepatocellular carcinoma. These cancer SP cells display several properties attributable to stem cell-like cancer cells and have been implicated in tumor growth, progression, and metastasis. Here we provide a detailed protocol for the detection of putative cancer stem cells of the SP phenotype in human adherent breast cancer cell cultures.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674135     DOI: 10.1007/978-1-61779-854-2_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

Review 1.  Stem cells and cancer stem-like cells in endocrine tissues.

Authors:  Ricardo V Lloyd; Heather Hardin; Celina Montemayor-Garcia; Fabio Rotondo; Luis V Syro; Eva Horvath; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

2.  Intestinal stem cells and stem cell-based therapy for intestinal diseases.

Authors:  Mahmoud Shaaban Mohamed; Yun Chen; Chao-Ling Yao
Journal:  Cytotechnology       Date:  2014-07-01       Impact factor: 2.058

3.  Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype.

Authors:  Maximilian Boesch; Dominik Wolf; Sieghart Sopper
Journal:  Stem Cells Int       Date:  2015-12-20       Impact factor: 5.443

4.  Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin.

Authors:  Honghai Xia; Jun Cao; Qing Li; Yang Lv; Weidong Jia; Weihua Ren; Qingyu Cheng; Xiaoyuan Song; Geliang Xu
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

Review 5.  Soft Tissue Sarcoma Cancer Stem Cells: An Overview.

Authors:  Katia C Genadry; Silvia Pietrobono; Rossella Rota; Corinne M Linardic
Journal:  Front Oncol       Date:  2018-10-26       Impact factor: 6.244

Review 6.  Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour.

Authors:  Kamal Shaik Fakiruddin; Nadiah Ghazalli; Moon Nian Lim; Zubaidah Zakaria; Syahril Abdullah
Journal:  Int J Mol Sci       Date:  2018-07-27       Impact factor: 5.923

7.  Targeting of CD133+ Cancer Stem Cells by Mesenchymal Stem Cell Expressing TRAIL Reveals a Prospective Role of Apoptotic Gene Regulation in Non-Small Cell Lung Cancer.

Authors:  Kamal Shaik Fakiruddin; Moon Nian Lim; Norshariza Nordin; Rozita Rosli; Zubaidah Zakaria; Syahril Abdullah
Journal:  Cancers (Basel)       Date:  2019-08-28       Impact factor: 6.639

8.  PPARγ maintains ERBB2-positive breast cancer stem cells.

Authors:  X Wang; Y Sun; J Wong; D S Conklin
Journal:  Oncogene       Date:  2013-06-17       Impact factor: 9.867

Review 9.  Cancer Stem Cells in Soft-Tissue Sarcomas.

Authors:  Paula Martínez-Delgado; Serena Lacerenza; Antonia Obrador-Hevia; Maria Lopez-Alvarez; José L Mondaza-Hernandez; Elena Blanco-Alcaina; Paloma Sanchez-Bustos; Nadia Hindi; David S Moura; Javier Martin-Broto
Journal:  Cells       Date:  2020-06-10       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.